# A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis

> **NCT04227288** · PHASE4 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 6 (actual)

## Conditions studied

- Nail Psoriasis

## Interventions

- **DRUG:** Enstilar Foam

## Key facts

- **NCT ID:** NCT04227288
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04227288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04227288, "A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04227288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*